Bimatoprost/timolol fixed combination (BTFC) in patients with primary open angle glaucoma or ocular hypertension in Greece | Zendy

Tryfon Rotsos | Zendy; Vasso G Kliafa | Zendy; Kevin J Asher | Zendy; Dimitrios Papaconstantinou | Zendy

Open Access

Bimatoprost/timolol fixed combination (BTFC) in patients with primary open angle glaucoma or ocular hypertension in Greece

Author(s) -

Tryfon Rotsos,

Vasso G Kliafa,

Kevin J Asher,

Dimitrios Papaconstantinou

Publication year - 2015

Publication title -

international journal of ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 29

eISSN - 2227-4898

pISSN - 2222-3959

DOI - 10.18240/ijo.2016.01.12

Subject(s) - medicine , tolerability , bimatoprost , glaucoma , timolol , ocular hypertension , intraocular pressure , adverse effect , open angle glaucoma , ophthalmology , clinical endpoint , clinical trial

To evaluate the efficacy and tolerability of the fixed combination of bimatoprost 0.03% and timolol 0.5% (BTFC) in patients in Greece with primary open angle glaucoma (POAG) or ocular hypertension (OHT) whose previous therapy provided insufficient lowering of intraocular pressure (IOP).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research